Author(s):
Zuber Khan, Syed Sufian Ahmad, Mumtaz, Nishat Amina, Mohammad Ahmed Khan
Email(s):
khan.ahmed1511@gmail.com
DOI:
10.52711/0974-360X.2025.00536 
Address:
Zuber Khan1, Syed Sufian Ahmad1, Mumtaz1, Nishat Amina2, Mohammad Ahmed Khan1
1Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, India.
2Department of Radiodiagnosis, Lady Hardinge Medical College and Associated SSK Hospital, New Delhi -110001, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 8,
Year - 2025
ABSTRACT:
Among the medications that are administered most commonly are proton pump inhibitors (PPI). There may be a connection between PPI usage and a higher chance of dementia, according to previous studies. On the other hand, conflicting findings have been found in previously conducted studies on the linkage between PPI use and dementia. This study aims to evaluate the association between PPI use and the risk of dementia among diabetes mellitus (DM) patients. The relationship between PPI use and dementia in diabetics was investigated using a comparative study. During a three-month evaluation period, 100 DM patients (56 of whom had been diagnosed with mild to severe dementia) and 44 controls were selected based on preset inclusion criteria. Data from both PPI and non-PPI users was compared. The findings revealed that PPI users had a higher risk of dementia than non-users (66% vs. 46%, respectively; OR 2.33; 95% CI 1.04, 5.25; p<0.01). Among patients with moderate dementia, a higher proportion were PPI users (59.9%) compared to non-users (20.3%). Conversely, non-PPI users had a greater prevalence of mild dementia (70.6%) compared to PPI users (40.3%). Notably, no cases of severe dementia were observed during the study period. These findings provide credence to the theory that DM patients who take PPI for an extended period of time may be at higher risk of developing dementia.
Cite this article:
Zuber Khan, Syed Sufian Ahmad, Mumtaz, Nishat Amina, Mohammad Ahmed Khan. Exploring the use of Proton Pump Inhibitor and Dementia Risk in Diabetes Mellitus Patients: A Cross-Sectional Study based Approach. Research Journal Pharmacy and Technology. 2025;18(8):3723-9. doi: 10.52711/0974-360X.2025.00536
Cite(Electronic):
Zuber Khan, Syed Sufian Ahmad, Mumtaz, Nishat Amina, Mohammad Ahmed Khan. Exploring the use of Proton Pump Inhibitor and Dementia Risk in Diabetes Mellitus Patients: A Cross-Sectional Study based Approach. Research Journal Pharmacy and Technology. 2025;18(8):3723-9. doi: 10.52711/0974-360X.2025.00536 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-8-39
REFERENCES:
1. Aarsland D. Epidemiology and Pathophysiology of Dementia-Related Psychosis. J Clin Psychiatry. 2020; Sep 15; 81(5): AD19038BR1C. doi: 10.4088/JCP.AD19038BR1C. PMID: 32936544.
2. Zhang P, Li Z, Chen P, Zhang A, Zeng Y, Zhang X, Huang Q, Liu D, Qi S, Mao C. Regular proton pump inhibitor use and incident dementia: population-based cohort study. BMC Med. 2022; Sep 1; 20(1): 271. doi: 10.1186/s12916-022-02478-y. PMID: 36045363; PMCID: PMC9434890.
3. Grossman M, Irwin DJ. The Mental Status Examination in Patients With Suspected Dementia. Continuum (Minneap Minn). 2016; Apr; 22(2 Dementia): 385-403. doi: 10.1212/CON.0000000000000298. PMID: 27042900; PMCID: PMC5390931.
4. Moelter ST, Glenn MA, Xie SX, Chittams J, Clark CM, Watson M, Arnold SE. The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores. Alzheimer Dis Assoc Disord. 2015; Apr-Jun; 29(2): 158-60. doi: 10.1097/WAD.0000000000000031. PMID: 24770371; PMCID: PMC4208973.
5. Chen LY, Lin HJ, Wu WT, Chen YC, Chen CL, Kao J, You SL, Chou YC, Sun CA. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study. Int J Environ Res Public Health. 2020; Nov 9; 17(21): 8271. doi: 10.3390/ijerph17218271. PMID: 33182362; PMCID: PMC7664895.
6. Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. 2019; Oct 22; 322(16): 1589-1599. doi: 10.1001/jama.2019.4782. PMID: 31638686; PMCID: PMC7462122.
7. Corsonello A, Maggio M, Fusco S, Adamo B, Amantea D, Pedone C, Garasto S, Ceda GP, Corica F, Lattanzio F, Antonelli Incalzi R. Proton pump inhibitors and functional decline in older adults discharged from acute care hospitals. J Am Geriatr Soc. 2014; Jun; 62(6): 1110-5. doi: 10.1111/jgs.12826. Epub 2014 May 6. PMID: 24801793.
8. Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, Doblhammer G, Haenisch B. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. JAMA Neurol. 2016; Apr; 73(4): 410-6. doi: 10.1001/jamaneurol.2015.4791. PMID: 26882076.
9. Haenisch B, von Holt K, Wiese B, Prokein J, Lange C, Ernst A, Brettschneider C, König HH, Werle J, Weyerer S, Luppa M, Riedel-Heller SG, Fuchs A, Pentzek M, Weeg D, Bickel H, Broich K, Jessen F, Maier W, Scherer M. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci. 2015; Aug; 265(5): 419-28. doi: 10.1007/s00406-014-0554-0. Epub 2014 Oct 24. PMID: 25341874.
10. Schoenfeld AJ, Grady D. Adverse Effects Associated With Proton Pump Inhibitors. JAMA Intern Med. 2016; Feb; 176(2): 172-4. doi: 10.1001/jamainternmed.2015.7927. PMID: 26751904.
11. Yibirin M, De Oliveira D, Valera R, Plitt AE, Lutgen S. Adverse Effects Associated with Proton Pump Inhibitor Use. Cureus. 2021; Jan 18; 13(1): e12759. doi: 10.7759/cureus.12759. PMID: 33614352; PMCID: PMC7887997.
12. Tai SY, Chien CY, Wu DC, Lin KD, Ho BL, Chang YH, Chang YP. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan. PLoS One. 2017; Feb 15; 12(2): e0171006. doi: 10.1371/journal.pone.0171006. PMID: 28199356; PMCID: PMC5310771.
13. Maher D, Ailabouni N, Mangoni AA, Wiese MD, Reeve E. Alterations in drug disposition in older adults: a focus on geriatric syndromes. Expert Opin Drug Metab Toxicol. 2021; Jan; 17(1): 41-52. doi: 10.1080/17425255.2021.1839413. Epub 2020 Nov 2. PMID: 33078628.
14. Jatoi S, Hafeez A, Riaz SU, Ali A, Ghauri MI, Zehra M. Low Vitamin B12 Levels: An Underestimated Cause Of Minimal Cognitive Impairment And Dementia. Cureus. 2020; Feb 13; 12(2): e6976. doi: 10.7759/cureus.6976. PMID: 32206454; PMCID: PMC7077099.
15. Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017; Sep; 8(9): 273-297. doi: 10.1177/2042098617715381. Epub 2017 Jun 29. PMID: 28861211; PMCID: PMC5557164.
16. Schwabe U. Arzneiverordnungen 2012 im Überblick. Arzneiverordnungs-Report 2013: Aktuelle Daten, Kosten, Trends und Kommentare. 2013: 3-46.
17. Luo H, Fan Q, Xiao S, Chen K. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital. BMC Health Serv Res. 2018; Jul 11; 18(1): 537. doi: 10.1186/s12913-018-3358-5. PMID: 29996830; PMCID: PMC6042351.
18. Sakata Y, Tsuruoka N, Takedomi H, Akutagawa T, Shimoda R, Esaki M, Fujimoto K. A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan. Digestion. 2020; 101(3): 308-315. doi: 10.1159/000498967. Epub 2019 Mar 6. PMID: 30840949.
19. Heidelbaugh JJ, Goldberg KL, Inadomi JM. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care. 2010; Sep; 16(9): e228-34. PMID: 21250399.
20. Pasina, L., Nobili, A., Tettamanti, M., Salerno, F., Corrao, S., Marengoni, A., ... and REPOSI investigators. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. European Journal of Internal Medicine. 2011; 22(2): 205-210.
21. Badiola N, Alcalde V, Pujol A, Münter LM, Multhaup G, Lleó A, Coma M, Soler-López M, Aloy P. The proton-pump inhibitor lansoprazole enhances amyloid beta production. PLoS One. 2013; 8(3): e58837. doi: 10.1371/journal.pone.0058837. Epub 2013 Mar 8. PMID: 23520537; PMCID: PMC3592824.
22. Fallahzadeh MK, Borhani Haghighi A, Namazi MR. Proton pump inhibitors: predisposers to Alzheimer disease? J Clin Pharm Ther. 2010; Apr; 35(2): 125-6. doi: 10.1111/j.1365-2710.2009.01100.x. PMID: 20456731.
23. Mansuri F, Bhole PK, Parmar D. Study of dry eye disease in type 2 diabetes mellitus and its association with diabetic retinopathy in Western India. Indian J Ophthalmol. 2023; Apr; 71(4): 1463-1467. doi: 10.4103/IJO.IJO_2770_22. PMID: 37026283; PMCID: PMC10276693.
24. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Medical Journal. 2012; Jul; 27(4): 269.
25. Pradeepa, R., and Mohan, V. (2021). Epidemiology of type 2 diabetes in India. Indian Journal of Ophthalmology. 69(11): 2932-2938.
26. Ciardullo S, Rea F, Savaré L, Morabito G, Perseghin G, Corrao G. Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2671-e2679. doi: 10.1210/clinem/dgac231. PMID: 35428888; PMCID: PMC9202701.
27. Fritze T, Doblhammer G, Widmann CN, Heneka MT. Time course of dementia following sepsis in German health claims data. Neurol Neuroimmunol Neuroinflamm. 2020; Dec 8; 8(1): e911. doi: 10.1212/NXI.0000000000000911. PMID: 33293458; PMCID: PMC7803331.
28. Reinke C, Buchmann N, Fink A, Tegeler C, Demuth I, Doblhammer G. Diabetes duration and the risk of dementia: a cohort study based on German health claims data. Age Ageing. 2022; Jan 6; 51(1): afab231. doi: 10.1093/ageing/afab231. PMID: 34923587; PMCID: PMC8753043.
29. Subramanian M, Vasudevan K, Rajagopal A. Cognitive Impairment Among Older Adults With Diabetes Mellitus in Puducherry: A Community-Based Cross-Sectional Study. Cureus. 2021; Jan 4; 13(1): e12488. doi: 10.7759/cureus.12488. PMID: 33552796; PMCID: PMC7859562.
30. Cholerton B, Baker LD, Montine TJ, Craft S. Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach. Diabetes Spectr. 2016; Nov; 29(4): 210-219. doi: 10.2337/ds16-0041. PMID: 27899872; PMCID: PMC5111529.
31. Kinoshita Y, Ishimura N, Ishihara S. Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use. J Neurogastroenterol Motil. 2018 Apr 30; 24(2): 182-196. doi: 10.5056/jnm18001. PMID: 29605975; PMCID: PMC5885718.
32. Choudhary VS, Chaudhary G. A Descriptive Study to Assess the Knowledge Regarding Diabetes Mellitus, Its Risk Factors and Complication among the Rural Community Sadiq, Faridkot (Punjab). Asian Journal of Nursing Education and Research. 2015; 5(2): 251-3.
33. Sogalad MM. Effectiveness of Awareness Program on Dementia among the Elderly residing at Selected Old Age Home of Belgaum, Karnataka. Asian Journal of Nursing Education and Research. 2015; 5(1): 58-63.
34. Torres-Bondia F, de Batlle J, Galván L, Buti M, Barbé F, Piñol-Ripoll G. Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015. BMC Public Health. 2022; Apr 24; 22(1): 818. doi: 10.1186/s12889-022-13217-6. PMID: 35461252; PMCID: PMC9035259.
35. Sonagre V, Lulay P, Lingam M, Arutla S, Patel S, Kulkarni M. Current Advances in Technology of Proton Pump Inhibitor Formulations. Research Journal of Pharmacy and Technology. 2012; 5(1): 20-6.
36. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8; 396(10248): 413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30. Erratum in: Lancet. 2023; Sep 30; 402(10408):1132. doi: 10.1016/S0140-6736(23)02043-3. PMID: 32738937; PMCID: PMC7392084.
37. Prince V. A Study to Assess the knowledge, and attitude regarding Alzheimer's dementia among adults in Nanchiyampalayam at Dharapuram with a view of conducting an awareness programme on prevention of Alzheimer's Dementia. International Journal of Advances in Nursing Management. 2020; 8(2): 149-53.
38. Gray SL, Walker RL, Dublin S, Yu O, Aiello Bowles EJ, Anderson ML, Crane PK, Larson EB. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study. J Am Geriatr Soc. 2018; Feb; 66(2): 247-253. doi: 10.1111/jgs.15073. Epub 2017 Nov 14. PMID: 29134629; PMCID: PMC5809315.
39. Xiao X, Xiang S, Xu Q, Li J, Xiao J, Si Y. Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China. Aging Clin Exp Res. 2023; Mar; 35(3): 659-667. doi: 10.1007/s40520-023-02349-3. Epub 2023 Feb 8. PMID: 36754914; PMCID: PMC9908504.’
40. George D, Kachappillil AJ. The level of Memory Impairment among elderly in a rural community of Ernakulam District. Asian Journal of Nursing Education and Research. 2020; 10(1): 107-9.
41. Gray N, Picone G, Sloan F, Yashkin A. Relation between BMI and diabetes mellitus and its complications among US older adults. South Med J. 2015; Jan; 108(1): 29-36. doi: 10.14423/SMJ.0000000000000214. PMID: 25580754; PMCID: PMC4457375.
42. Haastrup PF, Thompson W, Søndergaard J, Jarbøl DE. Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic Clin Pharmacol Toxicol. 2018; Aug; 123(2): 114-121. doi: 10.1111/bcpt.13023. Epub 2018 May 24. PMID: 29658189.
43. Roy A, Sheeja S. A Descriptive study to assess the Knowledge regarding dementia in geriatrics among above the age group of 60 years in selected community area, Sakthikulangara, Kollam. International Journal of Nursing Education and Research. 2020; 8(2): 273-80.
44. Chidambaranathan AS, Madan V, Balu D, Balasubarmanium M. Novel and advanced method of tracking the dementia cases using global positioning system (GPS) incorporated cheek plumper an indispensable system in dentistry. Research Journal of Pharmacy and Technology. 2023; 16(6): 2843-6.
45. Al-Hussaniy HA, Al-Samydai A, Hajleh MN, Mayyas A, Oraibi AI. Selection and Progress of drugs for treating Dementia. Research Journal of Pharmacy and Technology. 2024; Apr 22; 17(4): 1674-8.
46. Ortiz-Guerrero G, Amador-Muñoz D, Calderón-Ospina CA, López-Fuentes D, Nava Mesa MO. Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences. Neural Plast. 2018; Mar 21; 2018: 5257285. doi: 10.1155/2018/5257285. PMID: 29755512; PMCID: PMC5883984.
47. Kumar SB. Role of Caffeine in Dementia, Alzheimer's, Parkinsonism, Bipolar Mood Disorder. Research Journal of Pharmacy and Technology. 2015; 8(11): 1582-7.
48. Khan Z, Mehan S, Saifi MA, Gupta GD, Narula AS, Kalfin R. Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks. Curr Alzheimer Res. 2024; Feb 28; 20(11): 739–57. doi: 10.2174/0115672050289946240223050737. Epub ahead of print. PMID: 38424433; PMCID: PMC11107432.
49. Galande T, Sharma D, Aphale P. To Study the efficacy of Plumbum Metallicum Homoeopathic Medicine in improving the Cognitive function in Elderly. Research Journal of Pharmacy and Technology. 2022; 15(12): 5537-40.